Finnes, H. D., Chaffee, K. G., Call, T. G., Ding, W., Kenderian, S. S., Bowen, D. A., . . . Parikh, S. A. (2016). Pharmacovigilance during Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) in Routine Clinical Practice. Leuk Lymphoma.
Citación estilo ChicagoFinnes, Heidi D., et al. "Pharmacovigilance During Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) in Routine Clinical Practice." Leuk Lymphoma 2016.
Cita MLAFinnes, Heidi D., et al. "Pharmacovigilance During Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) in Routine Clinical Practice." Leuk Lymphoma 2016.
Precaución: Estas citas no son 100% exactas.